X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (53451) 53451
Book Review (20472) 20472
Publication (6725) 6725
Book Chapter (488) 488
Book / eBook (255) 255
Conference Proceeding (170) 170
Dissertation (43) 43
Newspaper Article (22) 22
Reference (12) 12
Magazine Article (9) 9
Newsletter (8) 8
Data Set (4) 4
Presentation (2) 2
Trade Publication Article (2) 2
Transcript (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (46915) 46915
humans (36226) 36226
animals (26626) 26626
male (12376) 12376
female (11940) 11940
mice (11462) 11462
oncology (11069) 11069
cancer (9542) 9542
expression (8015) 8015
angiogenesis (7615) 7615
pharmacology & pharmacy (7249) 7249
cell biology (7060) 7060
research (6855) 6855
signal transduction (6657) 6657
inflammation (6557) 6557
proteins (5932) 5932
health aspects (5630) 5630
analysis (5378) 5378
gene expression (5346) 5346
rats (5308) 5308
apoptosis (5149) 5149
vascular endothelial growth factor (5061) 5061
care and treatment (5041) 5041
biochemistry & molecular biology (4985) 4985
receptor (4982) 4982
middle aged (4911) 4911
article (4863) 4863
rodents (4850) 4850
physiological aspects (4845) 4845
endothelial growth-factor (4639) 4639
medicine (4631) 4631
immunology (4604) 4604
research article (4503) 4503
tumors (4325) 4325
cells (4100) 4100
adult (4073) 4073
cell line, tumor (4064) 4064
multidisciplinary sciences (4062) 4062
aged (4018) 4018
kinases (3936) 3936
metastasis (3891) 3891
medicine, research & experimental (3827) 3827
activation (3825) 3825
disease models, animal (3760) 3760
receptors (3757) 3757
in-vivo (3746) 3746
cells, cultured (3717) 3717
cytokines (3534) 3534
medicine & public health (3494) 3494
antineoplastic agents - therapeutic use (3483) 3483
development and progression (3464) 3464
review (3385) 3385
physiology (3319) 3319
science (3285) 3285
signal transduction - drug effects (3205) 3205
genetic aspects (3198) 3198
mice, inbred c57bl (3175) 3175
growth-factor receptor (3031) 3031
in-vitro (2989) 2989
immunohistochemistry (2968) 2968
chemotherapy (2956) 2956
biology (2913) 2913
cell proliferation (2818) 2818
gene-expression (2688) 2688
neurosciences (2650) 2650
breast cancer (2625) 2625
abridged index medicus (2624) 2624
endothelium (2613) 2613
risk factors (2576) 2576
oxidative stress (2573) 2573
treatment outcome (2561) 2561
phosphorylation (2545) 2545
prognosis (2490) 2490
stem cells (2442) 2442
inhibition (2411) 2411
therapy (2399) 2399
studies (2398) 2398
endothelial-cells (2393) 2393
nf-kappa-b (2381) 2381
pathology (2363) 2363
ligands (2314) 2314
endocrinology & metabolism (2306) 2306
atherosclerosis (2290) 2290
hypertension (2289) 2289
hematology (2283) 2283
drug therapy (2257) 2257
growth (2256) 2256
cell proliferation - drug effects (2227) 2227
growth factors (2219) 2219
medical research (2196) 2196
diabetes (2139) 2139
antineoplastic agents - pharmacology (2084) 2084
breast-cancer (2072) 2072
angiogenesis inhibitors - therapeutic use (2051) 2051
rats, sprague-dawley (2049) 2049
vascular endothelial growth factor a - metabolism (2044) 2044
disease (2016) 2016
vegf (2009) 2009
biomedicine (1986) 1986
internal medicine (1971) 1971
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (174) 174
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Online Resources - Online (11) 11
UofT at Mississauga - Stacks (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UTL at Downsview - May be requested (4) 4
UofT at Scarborough - Stacks (4) 4
Dentistry (Harry R Abbott) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (53731) 53731
French (87) 87
Japanese (62) 62
German (57) 57
Spanish (36) 36
Chinese (23) 23
Polish (15) 15
Hungarian (14) 14
Russian (8) 8
Korean (6) 6
Italian (5) 5
Swedish (3) 3
Arabic (2) 2
Czech (2) 2
Danish (2) 2
Dutch (2) 2
Hebrew (2) 2
Bulgarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, pp. CD007419 - CD007419
Background Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor... 
CLINICAL-TRIAL | RANIBIZUMAB PLUS PROMPT | RANDOMIZED CONTROLLED-TRIAL | Receptors, Vascular Endothelial Growth Factor [therapeutic use] | DEFERRED LASER | MEDICINE, GENERAL & INTERNAL | PEGAPTANIB SODIUM | Bevacizumab [adverse effects; therapeutic use] | Laser Coagulation [methods] | Aptamers, Nucleotide [adverse effects; therapeutic use] | Network Meta-Analysis | QUALITY-OF-LIFE | Macular Edema [drug therapy; etiology; surgery] | Vascular Endothelial Growth Factor A [antagonists & inhibitors] | Visual Acuity [drug effects; physiology] | COST-EFFECTIVENESS | Angiogenesis Inhibitors [adverse effects; therapeutic use] | LASER PHOTOCOAGULATION | Randomized Controlled Trials as Topic | Ranibizumab [adverse effects; therapeutic use] | Recombinant Fusion Proteins [adverse effects; therapeutic use] | Quality of Life | INTRAVITREAL BEVACIZUMAB | Diabetic Retinopathy [complications] | Triamcinolone [adverse effects; therapeutic use] | VEGF TRAP-EYE | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Macular Edema - etiology | Ranibizumab - adverse effects | Visual Acuity - drug effects | Triamcinolone - adverse effects | Laser Coagulation - methods | Angiogenesis Inhibitors - therapeutic use | Angiogenesis Inhibitors - adverse effects | Triamcinolone - therapeutic use | Visual Acuity - physiology | Aptamers, Nucleotide - therapeutic use | Aptamers, Nucleotide - adverse effects | Macular Edema - surgery | Macular Edema - drug therapy | Index Medicus
Journal Article
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 11, pp. 2247 - 2254
Journal Article
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2016, Volume 169, pp. 68 - 72
Abstract Purpose To investigate a certain set of methodological limitations in published anti-VEGF randomized controlled trials (RCT). Design Descriptive... 
Ophthalmology | OPHTHALMOLOGY | MANAGEMENT | INTRAVITREAL BEVACIZUMAB | EFFICACY | SAMPLE-SIZE CALCULATIONS | RANIBIZUMAB | Bevacizumab - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - adverse effects | Bevacizumab - adverse effects | Humans | Recombinant Fusion Proteins - therapeutic use | Aptamers, Nucleotide - therapeutic use | Drug-Related Side Effects and Adverse Reactions - etiology | Male | Treatment Outcome | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Aptamers, Nucleotide - adverse effects | Drug-Related Side Effects and Adverse Reactions - epidemiology | Randomized Controlled Trials as Topic | Ranibizumab - adverse effects | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Drug-Related Side Effects and Adverse Reactions - diagnosis | Databases, Factual | Physiological aspects | Medical colleges | Vascular endothelial growth factor | Analysis | Eye diseases | Endothelial growth factors | Cataracts | Diabetic retinopathy | Internal medicine | Funding | Clinical trials | Impact factors | Studies | Macular degeneration | Medicine | Reading | Archives & records | Surgery | Journals | Diabetes | Drug dosages | Research methodology | Age | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2013, Volume 156, Issue 1, pp. 23 - 28.e2
Journal Article
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2015, Volume 160, Issue 4, pp. 739 - 748.e2
Journal Article
Journal Article